Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals Ireland Limited • GW Pharma Limited • Jazz Pharmaceuticals, Inc. • Celator Pharmaceuticals Inc. • Jazz Pharmaceuticals Research UK Limited • Gentium S.r.l. • Jazz Pharmaceuticals UK Holdings Limited • Jazz Financing Holdings Limited • Jazz Pharmaceuticals International Limited • Jazz Investments Europe Limited ...

IRS number

981032470

JAZZ stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

8-K

Results of Operations and Financial Condition

13 Jan 25

8-K

Departure of Directors or Certain Officers

16 Dec 24

8-K

Entry into a Material Definitive Agreement

26 Nov 24

8-K

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with For U.S. media and investors only

7 Nov 24

Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results

6 Nov 24

8-K

Termination of a Material Definitive Agreement

16 Oct 24

8-K

Jazz Pharmaceuticals Announces Private Offering of $850 Million of

1 Aug 24

Transcripts

View all

JAZZ

Earnings call transcript

2024 Q3

6 Nov 24

JAZZ

Earnings call transcript

2024 Q2

31 Jul 24

JAZZ

Earnings call transcript

2024 Q1

1 May 24

JAZZ

Earnings call transcript

2023 Q4

28 Feb 24

JAZZ

Earnings call transcript

2023 Q3

8 Nov 23

JAZZ

Earnings call transcript

2023 Q2

9 Aug 23

JAZZ

Earnings call transcript

2023 Q2

9 Aug 23

JAZZ

Earnings call transcript

2023 Q1

10 May 23

JAZZ

Earnings call transcript

2022 Q4

1 Mar 23

JAZZ

Earnings call transcript

2022 Q3

10 Nov 22

Latest ownership filings

View all

BRUCE C COZADD

5 Feb 25

144

Notice of proposed sale of securities

Notice of proposed sale of securities

2 Jan 25

Financial summary

Financial statements Chart JAZZ financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q3 2024

JAZZ institutional ownership history Ownership history

95.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	468	446	+4.9%
Opened positions	76	73	+4.1%
Closed positions	54	84	-35.7%
Increased positions	162	145	+11.7%
Reduced positions	153	161	-5.0%

13F shares	Current	Prev Q	Change
Total value	5.70 tn	5.29 tn	+7.7%
Total shares	57.62 mm	57.46 mm	+0.3%
Total puts	132.80 k	151.70 k	-12.5%
Total calls	187.80 k	155.10 k	+21.1%
Total put/call ratio	0.7	1.0	-27.7%

Largest owners	Shares	Value	Change
Vanguard	6.11 mm	$680.44 bn	-3.4%
BlackRock	5.87 mm	$654.27 bn	NEW
LSV Asset Management	2.49 mm	$277.85 mm	+0.5%
Pacer Advisors	2.10 mm	$233.89 bn	+15.3%
STT State Street	1.95 mm	$216.83 bn	-3.5%
Capital World Investors	1.82 mm	$202.67 bn	-9.9%
Dimensional Fund Advisors	1.71 mm	$190.99 bn	+40.3%
EcoR1 Capital	1.71 mm	$190.12 bn	+68.3%
JPM JPMorgan Chase & Co.	1.52 mm	$168.85 bn	-1.5%
AMP Ameriprise Financial	1.51 mm	$168.46 bn	+3.5%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	0.00	-6.15 mm	EXIT
BlackRock	5.87 mm	+5.87 mm	NEW
Baupost	0.00	-1.27 mm	EXIT
EcoR1 Capital	1.71 mm	+692.52 k	+68.3%
Citadel Advisors	1.05 mm	+664.82 k	+171.0%
Rubric Capital Management	0.00	-616.62 k	EXIT
Vestal Point Capital	900.00 k	-600.00 k	-40.0%
Dimensional Fund Advisors	1.71 mm	+492.15 k	+40.3%
Wedge Capital Management L L P	291.68 k	+291.68 k	NEW
Pacer Advisors	2.10 mm	+278.46 k	+15.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

JAZZ insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Feb 25	Bruce C Cozadd	Ordinary Shares	Sell	Dispose S	No	Yes	122.31	1,500	183.47 k	439,744
17 Jan 25	Samantha Pearce	Ordinary Shares	Payment of exercise	Dispose F	No	No	122.62	1,365	167.38 k	25,412
17 Jan 25	Samantha Pearce	Ordinary Shares	Grant	Acquire A	No	No	0	2,533	0.00	26,777
17 Jan 25	Neena M Patil	Ordinary Shares	Payment of exercise	Dispose F	No	No	122.62	1,905	233.59 k	37,118
17 Jan 25	Neena M Patil	Ordinary Shares	Grant	Acquire A	No	No	0	5,864	0.00	39,023
17 Jan 25	Patricia Carr	Ordinary Shares	Grant	Acquire A	No	No	0	1,641	0.00	8,237
17 Jan 25	Gala Renee D	Ordinary Shares	Payment of exercise	Dispose F	No	No	122.62	3,300	404.65 k	59,933
17 Jan 25	Gala Renee D	Ordinary Shares	Grant	Acquire A	No	No	0	7,741	0.00	63,233